Home » Newsletters » BioWorld Asia

BioWorld Asia

Oct. 11, 2000

View Archived Issues

Hybrigenics Raises $17.3M For Work In Functional Proteomics

Commission Seeks More Debate On Cloning Before Anarchy Rules

Nerve Growth Factor Could Help Pain Of Diabetes, AIDS

Protherics Gets FDA Approval For Antibody-Based Antivenom

Artemis, Sangamo, Exelixis Link For Knockout Mouse Generation

Phytopharm Considers Options Following Positive Canine Study

Compugen Enters Proteomics With High-Throughput System

Oxford Glyco Finds Heparanase Gene, Seeks To Exploit Discovery

Other News To Note

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.